rv1729
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2013 (NCT01813084)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rv1729
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02140346 | Phase 1 | Aug 1, 2014 | RespiVert, Sponsor GmbH |
| NCT02140320 | Phase 1 | Jul 1, 2014 | RespiVert, Sponsor GmbH |
| NCT01813084 | Phase 1 | May 1, 2013 | RespiVert, Sponsor GmbH |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| RespiVert | For profit | 3 | 3 | 1 | 2013 |
| Sponsor GmbH | Academic/Hospital | 3 | 0 | 1 | 2013 |
2 organizations
Page 1 / 1